Thus, the inhibition of IL-6, IL-8, MCP-1, ICAM-1, and iNOS might be a useful therapeutic approach to ameliorate the pathogenesis of chronic inflammatory diseases such as AMD. This evidence concerns the gene IL6 and age-related macular degeneration.